357 related articles for article (PubMed ID: 21767775)
1. Pruritus: management algorithms and experimental therapies.
Steinhoff M; Cevikbas F; Ikoma A; Berger TG
Semin Cutan Med Surg; 2011 Jun; 30(2):127-37. PubMed ID: 21767775
[TBL] [Abstract][Full Text] [Related]
2. Approach to the Patient with Chronic Pruritus.
Lipman ZM; Ingrasci G; Yosipovitch G
Med Clin North Am; 2021 Jul; 105(4):699-721. PubMed ID: 34059246
[TBL] [Abstract][Full Text] [Related]
3. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy.
Cassano N; Tessari G; Vena GA; Girolomoni G
Am J Clin Dermatol; 2010 Dec; 11(6):399-411. PubMed ID: 20866115
[TBL] [Abstract][Full Text] [Related]
4. Chronic pruritus.
Ständer S; Grundmann SA
G Ital Dermatol Venereol; 2012 Apr; 147(2):161-9. PubMed ID: 22481579
[TBL] [Abstract][Full Text] [Related]
5. Itch Management: Systemic Agents.
Pongcharoen P; Fleischer AB
Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
[TBL] [Abstract][Full Text] [Related]
6. Itch Management in the Elderly.
Leslie TA
Curr Probl Dermatol; 2016; 50():192-201. PubMed ID: 27578088
[TBL] [Abstract][Full Text] [Related]
7. Novel agents for intractable itch.
Lynde CB; Kraft JN; Lynde CW
Skin Therapy Lett; 2008 Feb; 13(1):6-9. PubMed ID: 18357364
[TBL] [Abstract][Full Text] [Related]
8. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic advances in the systemic treatment of itch.
Summey BT; Yosipovitch G
Dermatol Ther; 2005; 18(4):328-32. PubMed ID: 16297005
[TBL] [Abstract][Full Text] [Related]
10. Innovative management of pruritus.
Feramisco JD; Berger TG; Steinhoff M
Dermatol Clin; 2010 Jul; 28(3):467-78. PubMed ID: 20510757
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Neuropathic Itch.
Rosen JD; Fostini AC; Yosipovitch G
Dermatol Clin; 2018 Jul; 36(3):213-224. PubMed ID: 29929594
[TBL] [Abstract][Full Text] [Related]
12. Topical therapies for pruritus.
Elmariah SB; Lerner EA
Semin Cutan Med Surg; 2011 Jun; 30(2):118-26. PubMed ID: 21767774
[TBL] [Abstract][Full Text] [Related]
13. Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus.
Cotes ME; Swerlick RA
Dermatol Ther; 2013; 26(2):120-34. PubMed ID: 23551369
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Itch Management.
Rowe B; Yosipovitch G
Curr Probl Dermatol; 2016; 50():149-54. PubMed ID: 27578084
[TBL] [Abstract][Full Text] [Related]
15. Itch in Urticaria Management.
Deza G; Giménez-Arnau AM
Curr Probl Dermatol; 2016; 50():77-85. PubMed ID: 27578075
[TBL] [Abstract][Full Text] [Related]
16. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Ständer S; Yosipovitch G
Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
[TBL] [Abstract][Full Text] [Related]
17. Itch associated with skin disease: advances in pathophysiology and emerging therapies.
Yosipovitch G; Fleischer A
Am J Clin Dermatol; 2003; 4(9):617-22. PubMed ID: 12926980
[TBL] [Abstract][Full Text] [Related]
18. Current topical and systemic therapies for itch.
Leslie TA; Greaves MW; Yosipovitch G
Handb Exp Pharmacol; 2015; 226():337-56. PubMed ID: 25861788
[TBL] [Abstract][Full Text] [Related]
19. 2020 guidelines for the diagnosis and treatment of cutaneous pruritus.
Satoh T; Yokozeki H; Murota H; Tokura Y; Kabashima K; Takamori K; Shiohara T; Morita E; Aiba S; Aoyama Y; Hashimoto T; Katayama I
J Dermatol; 2021 Sep; 48(9):e399-e413. PubMed ID: 34288036
[TBL] [Abstract][Full Text] [Related]
20. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
